SEARCH

SEARCH BY CITATION

References

  • Abo-Krysha N. and Rashed L. (2008) The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study. Mult. Scler. 14, 602608.
  • Aboul-Enein F., Rauschka H., Kornek B., Stadelmann C., Stefferl A., Bruck W., Lucchinetti C., Schmidbauer M., Jellinger K. and Lassmann H. (2003) Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J. Neuropathol. Exp. Neurol. 62, 2533.
  • Adamo A. M., Paez P. M., Escobar Cabrera O. E., Wolfson M., Franco P. G., Pasquini J. M. and Soto E. F. (2006) Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin. Exp. Neurol. 198, 519529.
  • Adams C. W. M. (1988) Perivascular iron deposition and other vascular damage in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 51, 260265.
  • Adams C. W. M. (1989) A Color Atlas of Multiple Sclerosis and Other Myelin Disorders. Sheridan Medical Books, Dobbs Ferry, New York.
  • Adams C. W., Poston R. N. and Buk S. J. (1989) Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J. Neurol. Sci. 92, 291306.
  • Alexander G. E. and Crutcher M. D. (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13, 266271.
  • Algarín C., Peirano P., Garrido M., Pizarro F. and Lozoff B. (2003) Iron deficiency anemia in infancy: long-lasting effects on auditory and visual system functioning. Pediatr. Res. 53, 217223.
  • Andrews H., White K., Thomson C., Edgar J., Bates D., Griffiths I., Turnbull D. and Nichols P. (2006) Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the Shiverer mouse. J. Neurosci. Res. 83, 15331539.
  • Ates O., Kurt S., Bozkurt N. and Karaer H. (2010) NRAMP1 (SLC11A1) variants: genetic susceptibility to multiple Sclerosis. J. Clin. Immunol. 30, 583586.
  • Auriel E., Karni A., Bornstein N. M., Nissel T., Gadoth A. and Hallevi H. (2011) Extra-cranial venous flow in patients with multiple sclerosis. J. Neurol. Sci. 309, 102104.
  • Badaracco M. E., Ortiz E. H., Soto E. F., Connor J. and Pasquini J. M. (2008) Effect of transferrin on hypomyelination induced by iron deficiency. J. Neurosci. Res. 86, 26632673.
  • Baeten K., Hendriks J. J., Hellings N., Theunissen E., Vanderlocht J., Ryck L. D., Gelan J., Stinissen P. and Adriaensens P. (2008) Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imaging. J. Neuroimmunol. 195, 16.
  • Bakshi R., Miletich R. S., Kinkel P. R., Emmet M. L. and Kinkel W. R. (1998) High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J. Neuroimaging 8, 228234.
  • Bakshi R., Shaikh Z. A. and Janardhan V. (2000) MRI T2 shortening (‘black T2’) in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport 11, 1521.
  • Bakshi R., Benedict R. H., Bermel R. A., Caruthers S. D., Puli S. R., Tjoa C. W., Fabiano A. J. and Jacobs L. (2002) T2 hypointensity in the deep gray matter of patients with multiple sclerosis, a quantitative magnetic resonance imaging study. Arch. Neurol. 59, 6268.
  • Balla G., Jacob H. S., Balla J., Rosenberg M., Nath K., Apple F., Eaton J. W. and Vercellotti G. M. (1992) Ferritin: a cytoprotective antioxidant strategem of endothelium. J. Biol. Chem. 267, 1814818153.
  • Barbeito A. G., Garringer H. J., Baraibar M. A., Gao X., Arredondo M., Nunez M. T., Smith M. A., Ghetti B. and Vidal R. (2009) Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene. J. Neurochem. 109, 10671078.
  • Bartnik B. L., Juurlink B. H. and Devon R. M. (2000) Macrophages: their myelinotrophic or neurotoxic actions depend upon tissue oxidative stress. Mult. Scler. 6, 3742.
  • Bartolome S., Dhillon N. K., Buch S., Casillan A. J., Wood J. G. and O’Brien-Ladner A. R. (2009) Deferoxamine mimics the pattern of hypoxia-related injury at the microvasculature. Shock 31, 481485.
  • Berg D. and Youdim M. B. (2006) Role of iron in neurodegenerative disorders. Top. Magn. Reson. Imaging 17, 517.
  • Bermel R. A., Puli S. R., Rudick R. A., Weinstock-Guttman B., Fisher E., Munschauer 3rd F. E. and Bakshi R. (2005) Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch. Neurol. 62, 13711376.
  • Bertoni-Freddari C., Fattoretti P., Casoli T., Di Stefano G., Solazzi M., Perna E. and De Angelis C. (2006) Reactive structural dynamics of synaptic mitochondria in ischemic delayed neuronal death. Ann. NY Acad. Sci. 1090, 2634.
  • Bianchi L., Tacchini L. and Cairo G. (1999) HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. Nucleic Acids Res. 27, 42234227.
  • Biswas S., Biesiada H., Williams T. D. and LeVine S. M. (2002) Delayed clinical and pathological signs in twitcher (globoid cell leukodystrophy) mice on a C57BL/6 x CAST/Ei background. Neurobiol. Dis. 10, 344357.
  • Bjartmar C. and Trapp B. D. (2001) Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr. Opin. Neurol. 14, 271278.
  • Blinkenberg M., Jensen C. V., Holm S., Paulson O. B. and Sorensen P. S. (1999) A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS. Neurology 53, 149153.
  • Bolton C. and Paul C. (2006) Glutamate receptors in neuroinflammatory demyelinating disease. Mediators Inflamm. 2006, 93684.
  • Boretius S., Schmelting B., Watanabe T., Merkler D., Tammer R., Czeh B., Michaelis T., Frahm J. and Fuchs E. (2006) Monitoring of EAE onset and progression in the common marmoset monkey by sequential high-resolution 3D MRI. NMR Biomed. 19, 4149.
  • Bowern N., Ramshaw I. A., Clark I. A. and Doherty P. C. (1984) Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J. Exp. Med. 160, 15321543.
  • Bowlus C. L. (2003) The role of iron in T cell development and autoimmunity. Autoimmun. Rev. 2, 7378.
  • Brass S. D., Benedict R. H., Weinstock-Guttman B., Munschauer F. and Bakshi R. (2006a) Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult. Scler. 12, 437444.
  • Brass S. D., Chen N. K., Mulkern R. V. and Bakshi R. (2006b) Magnetic resonance imaging of iron deposition in neurological disorders. Top. Magn. Reson. Imaging 17, 3140.
  • Brett R. and Rumsby M. G. (1993) Evidence of free radical damage in the central nervous system of guinea-pigs at the prolonged acute and early relapse stages of chronic relapsing experimental allergic encephalomyelitis. Neurochem. Int. 23, 3544.
  • Brochet B., Deloire M. S., Touil T., Anne O., Caille J. M., Dousset V. and Petry K. G. (2006) Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE. Neuroimage 32, 266274.
  • Brown G. C. and Neher J. J. (2010) Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol. Neurobiol. 41, 242247.
  • Burdo J. R., Menzies S. L., Simpson I. A., Garrick L. M., Garrick M. D., Dolan K. G., Haile D. J., Beard J. L. and Connor J. R. (2001) Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 66, 11981207.
  • Burdo J. R., Antonetti D. A., Wolpert E. B. and Connor J. R. (2003) Mechanisms and regulation of transferrin and iron transport in a model blood–brain barrier system. Neuroscience 121, 883890.
  • Calabrese V., Scapagnini G., Ravagna A., Bella R., Butterfield D. A., Calvani M., Pennisi G. and Giuffrida Stella A. M. (2003) Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine. Neurochem. Res. 28, 13211328.
  • Carbonell T. and Rama R. (2007) Iron, oxidative stress and early neurological deterioration in ischemic stroke. Curr. Med. Chem. 14, 857874.
  • Casciola-Rosen L., Wigley F. and Rosen A. (1997) Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J. Exp. Med. 185, 7179.
  • Cassan C. and Liblau R. S. (2007) Immune tolerance and control of CNS autoimmunity: from animal models to MS patients. J. Neurochem. 100, 883892.
  • Ceccarelli A., Filippi M., Neema M., Arora A., Valsasina P., Rocca M. A., Healy B. C. and Bakshi R. (2009) T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis. Mult. Scler. 15, 678686.
  • Ceccarelli A., Rocca M. A., Neema M., Martinelli V., Arora A., Tauhid S., Ghezzi A., Comi G., Bakshi R. and Filippi M. (2010) Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis. Mult. Scler. 16, 3944.
  • Ceccarelli A., Rocca M. A., Perego E., Moiola L., Ghezzi A., Martinelli V., Comi G. and Filippi M. (2011) Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis. Mult. Scler. 17, 702707.
  • Centonze D., Muzio L., Rossi S., Furlan R., Bernardi G. and Martino G. (2010) The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death Differ. 17, 10831091.
  • Chakrabarty A., Emerson M. R. and LeVine S. M. (2003) Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis. Mult. Scler. 9, 372381.
  • Chakravarti S., Sabatos C. A., Xiao S., Illes Z., Cha E. K., Sobel R. A., Zheng X. X., Strom T. B. and Kuchroo V. K. (2005) Tim-2 regulates T helper type 2 responses and autoimmunity. J. Exp. Med. 202, 437444.
  • Cheah J. H., Kim S. F., Hester L. D., Clancy K. W., Patterson 3rd S. E., Papadopoulos V. and Snyder S. H. (2006) NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 51, 431440.
  • Cheepsunthorn P., Palmer C. and Connor J. R. (1998) Cellular distribution of ferritin subunits in postnatal rat brain. J. Comp. Neurol. 400, 7386.
  • Chen-Roetling J., Chen L. and Regan R. F. (2011) Apotransferrin protects cortical neurons from hemoglobin toxicity. Neuropharmacology 60, 423431.
  • Chi S. I., Wang C. K., Chen J. J., Chau L. Y. and Lin T. N. (2000) Differential regulation of H- and L-ferritin messenger RNA subunits, ferritin protein and iron following focal cerebral ischemia-reperfusion. Neuroscience 100, 475484.
  • Chi O. Z., Hunter C., Liu X. and Weiss H. R. (2008) Effects of deferoxamine on blood-brain barrier disruption and VEGF in focal cerebral ischemia. Neurol. Res. 30, 288293.
  • Chin C. L., Pai M., Bousquet P. F., Schwartz A. J., O’Connor E. M., Nelson C. M., Hradil V. P., Cox B. F., McRae B. L. and Fox G. B. (2009) Distinct spatiotemporal pattern of CNS lesions revealed by USPIO-enhanced MRI in MOG-induced EAE rats implicates the involvement of spino-olivocerebellar pathways. J. Neuroimmunol. 211, 4955.
  • Choi I. Y., Lee S. P., Denney D. R. and Lynch S. G. (2011) Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T. Mult. Scler. 17, 289296.
  • Ciccarelli O., Altmann D. R., McLean M. A., Wheeler-Kingshott C. A., Wimpey K., Miller D. H. and Thompson A. J. (2010) Spinal cord repair in MS: does mitochondrial metabolism play a role? Neurology 74, 721727.
  • Comabella M., Altet L., Peris F., Villoslada P., Sánchez A. and Montalban X. (2004) Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients. Mult. Scler. 10, 618620.
  • Connor J. R. and Menzies S. L. (1990) Altered cellular distribution of iron in the central nervous system of myelin deficient rats. Neuroscience 34, 265271.
  • Connor J. R. and Menzies S. L. (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17, 8393.
  • Connor J. R., Menzies S. L., St Martin S. M. and Mufson E. J. (1990) Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J. Neurosci. Res. 27, 595611.
  • Connor J. R., Pavlick G., Karli D., Menzies S. L. and Palmer C. (1995) A histochemical study of iron-positive cells in the developing rat brain. J. Comp. Neurol. 355, 111123.
  • Connor J. R., Ponnuru P., Wang X. S., Patton S. M., Allen R. P. and Earley C. J. (2011) Profile of altered brain iron acquisition in restless legs syndrome. Brain 134, 959968.
  • Cooper C. E., Lynagh G. R., Hoyes K. P., Hider R. C., Cammack R. and Porter J. B. (1996) The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase. J. Biol. Chem. 271, 2029120299.
  • Craelius W., Migdal M. W., Luessenhop C. P., Sugar A. and Mihalakis I. (1982) Iron deposits surrounding multiple sclerosis plaques. Arch. Pathol. Lab. Med. 106, 397399.
  • Crichton R. R., Wilmet S., Legssyer R. and Ward R. J. (2002) Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J. Inorg. Biochem. 91, 918.
  • Crichton R. R., Dexter D. T. and Ward R. J. (2011) Brain iron metabolism and its perturbation in neurological diseases. J. Neural. Transm. 118, 301314.
  • Crompton D. E., Chinnery P. F., Fey C. et al. (2002) Neuroferritinopathy: a window on the role of iron in neurodegeneration. Blood Cells Mol. Dis. 29, 522531.
  • Cunnea P., Ni Mháille A., McQuaid S., Farrell M., McMahon J. and FitzGerald U. (2011) Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis. Mult. Scler. 17, 808818.
  • De Stefano N., Narayanan S., Francis G. S., Arnaoutelis R., Tartaglia M. C., Antel J. P., Matthews P. M. and Arnold D. L. (2001) Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch. Neurol. 58, 6570.
  • Deng X., Vidal R. and Englander E. W. (2010) Accumulation of oxidative DNA damage in brain mitochondria in mouse model of hereditary ferritinopathy. Neurosci. Lett. 479, 4448.
  • Doepp F., Paul F., Valdueza J. M., Schmierer K. and Schreiber S. J. (2010) No cerebrocervical venous congestion in patients with multiple sclerosis. Ann. Neurol. 68, 173183.
  • Domercq M., Sánchez-Gómez M. V., Sherwin C., Etxebarria E., Fern R. and Matute C. (2007) System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J. Immunol. 178, 65496556.
  • Dousset V., Ballarino L., Delalande C., Coussemacq M., Canioni P., Petry K. G. and Caille J. M. (1999) Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis. AJNR Am. J. Neuroradiol. 20, 223227.
  • Drayer B., Burger P., Hurwitz B., Dawson D. and Cain J. (1987a) Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am. J. Roentgenol. 149, 357363.
  • Drayer B. P., Burger P., Hurwitz B., Dawson D., Cain J., Leong J., Herfkens R. and Johnson G. A. (1987b) Magnetic resonance imaging in multiple sclerosis: decreased signal in thalamus and putamen. Ann. Neurol. 22, 546550.
  • Dunn L. L., Rahmanto Y. S. and Richardson D. R. (2007) Iron uptake and metabolism in the new millennium. Trends Cell Biol. 17, 93100.
  • Dutta R. and Trapp B. D. (2007) Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68, S22S31.
  • Dutta R. and Trapp B. D. (2011) Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog. Neurobiol. 93, 112.
  • Dwork A. J., Schon E. A. and Herbert J. (1988) Nonidentical distribution of transferrin and ferric iron in human brain. Neuroscience 27, 333345.
  • Erb G. L., Osterbur D. L. and LeVine S. M. (1996) The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry. Brain Res. Dev. Brain Res. 93, 120128.
  • Espinosa-Jeffrey A., Kumar S., Zhao P. M., Awosika O., Agbo C., Huang A., Chang R. and De Vellis J. (2002) Transferrin regulates transcription of the MBP gene and its action synergizes with IGF-1 to enhance myelinogenesis in the md rat. Dev. Neurosci. 24, 227241.
  • Fan Y., Wang J., Wei L., He B., Wang C. and Wang B. (2011) Iron deficiency activates pro-inflammatory signaling in macrophages and foam cells via the p38 MAPK-NF-kappaB pathway. Int. J. Cardiol. 152, 4955.
  • Ferretti G., Bacchetti T., DiLudovico F., Viti B., Angeleri V. A., Danni M. and Provinciali L. (2006) Intracellular oxidative activity and respiratory burst of leukocytes isolated from multiple sclerosis patients. Neurochem. Int. 48, 8792.
  • Fisher M., Levine P. H., Weiner B. H., Vaudreuil C. H., Natale A., Johnson M. H. and Hoogasian J. J. (1988) Monocyte and polymorphonuclear leukocyte toxic oxygen metabolite production in multiple sclerosis. Inflammation 12, 123131.
  • Fisher J., Devraj K., Ingram J., Slagle-Webb B., Madhankumar A. B., Liu X., Klinger M., Simpson I. A. and Connor J. R. (2007) Ferritin: a novel mechanism for delivery of iron to the brain and other organs. Am. J. Physiol. Cell Physiol. 293, C641C649.
  • Floris S., Blezer E. L., Schreibelt G., Dopp E., van der Pol S. M., Schadee-Eestermans I. L., Nicolay K., Dijkstra C. D. and de Vries H. E. (2004) Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 127, 616627.
  • Forge J. K., Pedchenko T. V. and LeVine S. M. (1998) Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. Life Sci. 63, 22712284.
  • Francois C., Nguyen-Legros J. and Percheron G. (1981) Topographical and cytological localization of iron in rat and monkey brains. Brain Res. 215, 317322.
  • Gaasch J. A., Geldenhuys W. J., Lockman P. R., Allen D. D. and Van der Schyf C. J. (2007) Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures. Neurochem. Res. 32, 16861693.
  • Ganz T. (2009) Iron in innate immunity: starve the invaders. Curr. Opin. Immunol. 21, 6367.
  • Gazouli M., Sechi L., Paccagnini D., Sotgiu S., Arru G., Nasioulas G. and Vassilopoulos D. (2008) NRAMP1 polymorphism and viral factors in Sardinian multiple sclerosis patients. Can. J. Neurol. Sci. 35, 491494.
  • Ge Y., Law M., Johnson G., Herbert J., Babb J. S., Mannon L. J. and Grossman R. I. (2005) Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am. J. Neuroradiol. 26, 15391547.
  • Ge Y., Jensen J. H., Lu H., Helpern J. A., Miles L., Inglese M., Babb J. S., Herbert J. and Grossman R. I. (2007) Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am. J. Neuroradiol. 28, 16391644.
  • Ge Y., Zohrabian V. M., Osa E. O., Xu J., Jaggi H., Herbert J., Haacke E. M. and Grossman R. I. (2009) Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla. J. Magn. Reson. Imaging 29, 11901194.
  • Gerber M. R. and Connor J. R. (1989) Do oligodendrocytes mediate iron regulation in the human brain? Ann. Neurol. 26, 9598.
  • Geurts J. J. and van Horssen J. (2010) The brake on neurodegeneration: increased mitochondrial metabolism in the injured MS spinal cord. Neurology 74, 710711.
  • Gille G. and Reichmann H. (2011) Iron-dependent functions of mitochondria – relation to neurodegeneration. J. Neural. Transm. 118, 349359.
  • Gotz M. E., Double K., Gerlach M., Youdim M. B. and Riederer P. (2004) The relevance of iron in the pathogenesis of Parkinson’s disease. Ann. NY Acad. Sci. 1012, 193208.
  • Grant S. M., Wiesinger J. A., Beard J. L. and Cantorna M. T. (2003) Iron-deficient mice fail to develop autoimmune encephalomyelitis. J. Nutr. 133, 26352638.
  • Grimaud J., Millar J., Thorpe J. W., Moseley I. F., McDonald W. I. and Miller D. H. (1995) Signal intensity on MRI of basal ganglia in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 59, 306308.
  • Gutsaeva D. R., Suliman H. B., Carraway M. S., Demchenko I. T. and Piantadosi C. A. (2006) Oxygen-induced mitochondrial biogenesis in the rat hippocampus. Neuroscience 137, 493504.
  • Haacke E. M., Makki M., Ge Y. et al. (2009) Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J. Magn. Reson. Imaging 29, 537544.
  • Haacke E. M., Garbern J., Miao Y., Habib C. and Liu M. (2010a) Iron stores and cerebral veins in MS studied by susceptibility weighted imaging. Int. Angiol. 29, 149157.
  • Haacke E. M., Miao Y., Liu M., Habib C. A., Katkuri Y., Liu T., Yang Z., Lang Z., Hu J. and Wu J. (2010b) Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults. J. Magn. Reson. Imaging 32, 561576.
  • Hallgren B. and Sourander P. (1958) The effect of age on the non-haemin iron in the human brain. J. Neurochem. 3, 4151.
  • Hammann K. P. and Hopf H. C. (1986) Monocytes constitute the only peripheral blood cell population showing an increased burst activity in multiple sclerosis patients. Int. Arch. Allergy Appl. Immunol. 81, 230234.
  • Han J., Seaman W. E., Di X., Wang W., Willingham M., Torti F. M. and Torti S. V. (2011) Iron Uptake Mediated by Binding of H-Ferritin to the TIM-2 Receptor in Mouse Cells. PLoS ONE 6(8), e23800.
  • Harada T., Baba M., Torii I. and Morikawa S. (1987) Ferritin selectively suppresses delayed-type hypersensitivity responses at induction or effector phase. Cell. Immunol. 109, 7588.
  • Hill J. M. and Switzer 3rd R. C. (1984) The regional distribution and cellular localization of iron in the rat brain. Neuroscience 11, 595603.
  • Hill J. M., Ruff M. R., Weber R. J. and Pert C. B. (1985) Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution. Proc. Natl Acad. Sci. USA 82, 45534557.
  • Hodges Y. K., Reese S. M., Pahl P. M. and Horwitz L. D. (2005) Paradoxical effects of iron chelation on growth of vascular endothelial cells. J. Cardiovasc. Pharmacol. 45, 539544.
  • Hogan V., White K., Edgar J., McGill A., Karim S., McLaughlin M., Griffiths I., Turnbull D. and Nichols P. (2009) Increase in mitochondrial density within axons and supporting cells in response to demyelination in the Plp1 mouse model. J. Neurosci. Res. 87, 452459.
  • Holley J. E., Newcombe J., Whatmore J. L. and Gutowski N. J. (2010) Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter. Neurosci. Lett. 470, 6570.
  • Honegger C. G., Krenger W. and Langemann H. (1989) Measurement of free radical scavengers in the spinal cord of rats with experimental autoimmune encephalomyelitis. Neurosci. Lett. 98, 327332.
  • Huang E., Ong W. Y., Go M. L. and Connor J. R. (2006) Upregulation of iron regulatory proteins and divalent metal transporter-1 isoforms in the rat hippocampus after kainate induced neuronal injury. Exp. Brain Res. 170, 376386.
  • Hulet S. W., Hess E. J., Debinski W., Arosio P., Bruce K., Powers S. and Connor J. R. (1999a) Characterization and distribution of ferritin binding sites in the adult mouse brain. J. Neurochem. 72, 868874.
  • Hulet S. W., Powers S. and Connor J. R. (1999b) Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains. J. Neurol. Sci. 165, 4855.
  • Hulet S. W., Heyliger S. O., Powers S. and Connor J. R. (2000) Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis. J. Neurosci. Res. 61, 5260.
  • Hulet S. W., Menzies S. and Connor J. R. (2002) Ferritin binding in the developing mouse brain follows a pattern similar to myelination and is unaffected by the jimpy mutation. Dev. Neurosci. 24, 208213.
  • Huynh C. and Andrews N. W. (2008) Iron acquisition within host cells and the pathogenicity of Leishmania. Cell Microbiol. 10, 293300.
  • Inglese M., Park S. J., Johnson G., Babb J. S., Miles L., Jaggi H., Herbert J. and Grossman R. I. (2007) Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch. Neurol. 64, 196202.
  • Jiang H., Song N., Xu H., Zhang S., Wang J. and Xie J. (2010) Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent. Cell Res. 20, 345356.
  • Juckett M. B., Balla J., Balla G., Jessurun J., Jacob H. S. and Vercellotti G. M. (1995) Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am. J. Pathol. 147, 782789.
  • Kalluri R., Cantley L. G., Kerjaschki D. and Neilson E. G. (2000) Reactive oxygen species expose cryptic epitopes associated with autoimmune goodpasture syndrome. J. Biol. Chem. 275, 2002720032.
  • Kaneko Y., Kitamoto T., Tateishi J. and Yamaguchi K. (1989) Ferritin immunohistochemistry as a marker for microglia. Acta Neuropathol. 79, 129136.
  • Kaur C. and Ling E. A. (1995) Transient expression of transferrin receptors and localisation of iron in amoeboid microglia in postnatal rats. J. Anat. 186, 165173.
  • Kaur C. and Ling E. A. (1999) Increased expression of transferrin receptors and iron in amoeboid microglial cells in postnatal rats following an exposure to hypoxia. Neurosci. Lett. 262, 1831869.
  • Kaur C. and Ling E. A. (2008) Blood brain barrier in hypoxic-ischemic conditions. Curr. Neurovasc. Res. 5, 7181.
  • Kaur C., Sivakumar V., Ang L. S. and Sundaresan A. (2006) Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity. J. Neurochem. 98, 12001216.
  • Keown P. and Descamps-Latscha B. (1983) In vitro suppression of cell-mediated immunity by ferroproteins and ferric salts. Cell. Immunol. 80, 257266.
  • Khalil M., Enzinger C., Langkammer C., Tscherner M., Wallner-Blazek M., Jehna M., Ropele S., Fuchs S. and Fazekas F. (2009) Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Mult. Scler. 15, 10481054.
  • Knickelbein J. E., de Souza A. J., Tosti R., Narayan P. and Kane L. P. (2006) Cutting edge: inhibition of T cell activation by TIM-2. J. Immunol. 177, 49664970.
  • Knutson M. and Wessling-Resnick M. (2003) Iron metabolism in the reticuloendothelial system. Crit. Rev. Biochem. Mol. Biol. 38, 6188.
  • Koeppen A. H., Dickson A. C. and McEvoy J. A. (1995) The cellular reactions to experimental intracerebral hemorrhage. J. Neurol. Sci. 134(Suppl), 102112.
  • Kotze M. J., de Villiers J. N., Rooney R. N., Grobbelaar J. J., Mansvelt E. P., Bouwens C. S., Carr J., Stander I. and du Plessis L. (2001) Analysis of the NRAMP1 gene implicated in iron transport: association with multiple sclerosis and age effects. Blood Cells Mol. Dis. 27, 4453.
  • Kotze M. J., de Villiers J. N., Warnich L., Schmidt S., Carr J., Mansvelt E., Fourie E. and van Rensburg S. J. (2006) Lack of clinical manifestation of hereditary haemochromatosis in South African patients with multiple sclerosis. Metab. Brain Dis. 21, 109120.
  • Kuchroo V. K., Umetsu D. T., DeKruyff R. H. and Freeman G. J. (2003) The TIM gene family: emerging roles in immunity and disease. Nat. Rev. Immunol. 3, 454462.
  • Kupershmidt L., Weinreb O., Amit T., Mandel S., Bar-Am O. and Youdim M. B. (2011) Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain. Neuroscience 189, 345358.
  • Kutzelnigg A. and Lassmann H. (2005) Cortical lesions and brain atrophy in MS. J. Neurol. Sci. 233, 5559.
  • Lall M. M., Ferrell J., Nagar S., Fleisher L. N. and McGahan M. C. (2008) Iron regulates L-cystine uptake and glutathione levels in lens epithelial and retinal pigment epithelial cells by its effect on cytosolic aconitase. Invest. Ophthalmol. Vis. Sci. 49, 310419.
  • Langemann H., Kabiersch A. and Newcombe J. (1992) Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis. Eur. Neurol. 32, 248252.
  • Langkammer C., Krebs N., Goessler W., Scheurer E., Ebner F., Yen K., Fazekas F. and Ropele S. (2010) Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 257, 455462.
  • Lassmann H. (2003) Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J. Neurol. Sci. 206, 187191.
  • Lassmann H. (2011) Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer’s disease. J. Neural. Transm. 118, 747752.
  • Law M., Saindane A. M., Ge Y., Babb J. S., Johnson G., Mannon L. J., Herbert J. and Grossman R. I. (2004) Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 231, 645652.
  • Leppert D., Ford J., Stabler G., Grygar C., Lienert C., Huber S., Miller K. M., Hauser S. L. and Kappos L. (1998) Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 121, 23272334.
  • LeVine S. M. (1991) Oligodendrocytes and myelin sheaths in normal, quaking and shiverer brains are enriched in iron. J. Neurosci. Res. 29, 413419.
  • LeVine S. M. (1997) Iron deposits in multiple sclerosis and Alzheimer’s disease brains. Brain Res. 760, 298303.
  • LeVine S. M. and Brown D. C. (1997) IL-6 and TNFalpha expression in brains of twitcher, quaking and normal mice. J. Neuroimmunol. 73, 4756.
  • LeVine S. M. and Chakrabarty A. (2004) The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann. NY Acad. Sci. 1012, 252266.
  • LeVine S. M. and Macklin W. B. (1990) Iron-enriched oligodendrocytes: a reexamination of their spatial distribution. J. Neurosci. Res. 26, 508512.
  • LeVine S. M. and Torres M. V. (1992) Morphological features of degenerating oligodendrocytes in twitcher mice. Brain Res. 587, 348352.
  • LeVine S. M. and Wetzel D. L. (1998) Chemical analysis of multiple sclerosis lesions by FT-IR microspectroscopy. Free Radic. Biol. Med. 25, 3341.
  • LeVine S. M., Lynch S. G., Ou C. N., Wulser M. J., Tam E. and Boo N. (1999) Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients. Brain Res. 821, 511515.
  • LeVine S. M., Maiti S., Emerson M. R. and Pedchenko T. V. (2002) Apoferritin attenuates experimental allergic encephalomyelitis in SJL mice. Dev. Neurosci. 24, 177183.
  • Li H., Swiercz R. and Englander E. W. (2009) Elevated metals compromise repair of oxidative DNA damage via the base excision repair pathway: implications of pathologic iron overload in the brain on integrity of neuronal DNA. J. Neurochem. 110, 17741783.
  • Li L., Fang C. J., Ryan J. C. et al. (2010) Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc. Natl Acad. Sci. USA 107, 35053510.
  • Lin H. H. and Connor J. R. (1989) The development of the transferrin-transferrin receptor system in relation to astrocytes, MBP and galactocerebroside in normal and myelin-deficient rat optic nerves. Brain Res. Dev. Brain Res. 49, 281293.
  • Liuzzi G. M., Trojano M., Fanelli M., Avolio C., Fasano A., Livrea P. and Riccio P. (2002) Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis. Mult. Scler. 8, 222228.
  • Lok C. N. and Ponka P. (1999) Identification of a hypoxia response element in the transferrin receptor gene. J. Biol. Chem. 274, 2414724152.
  • Lucchinetti C., Brück W., Parisi J., Scheithauer B., Rodriguez M. and Lassmann H. (1999) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122, 22792295.
  • Lynch S. G., Peters K. and LeVine S. M. (1996) Desferrioxamine in chronic progressive multiple sclerosis: a pilot study. Mult. Scler. 2, 157160.
  • Lynch S. G., Fonseca T. and LeVine S. M. (2000) A multiple course trial of desferrioxamine in chronic progressive multiple sclerosis. Cell. Mol. Biol. (Noisy-le-grand) 46, 865869.
  • Mackenzie B. and Hediger M. A. (2004) SLC11 family of H+-coupled metal-ion transporters NRAMP1 and DMT1. Pflugers Arch. 447, 571579.
  • MacMicking J. D., Willenborg D. O., Weidemann M. J., Rockett K. A. and Cowden W. B. (1992) Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176, 303307.
  • Maeda A. and Sobel R. A. (1996) Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55, 300309.
  • Mahad D., Lassmann H. and Turnbull D. (2008a) Review: mitochondria and disease progression in multiple sclerosis. Neuropathol. Appl. Neurobiol. 34, 577589.
  • Mahad D., Ziabreva I., Lassmann H. and Turnbull D. (2008b) Mitochondrial defects in acute multiple sclerosis lesions. Brain 131, 17221735.
  • Mairuae N., Connor J. R. and Cheepsunthorn P. (2011) Increased cellular iron levels affect matrix metalloproteinase expression and phagocytosis in activated microglia. Neurosci. Lett. 500, 3640.
  • Mao P. and Reddy P. H. (2010) Is multiple sclerosis a mitochondrial disease? Biochim. Biophys. Acta 1802, 6679.
  • Marder E., Gupta P., Greenberg B. M., Frohman E. M., Awad A. M., Bagert B. and Stüve O. (2011) No cerebral or cervical venous insufficiency in US veterans with multiple sclerosis. Arch. Neurol. (in press).
  • Mastroberardino P. G., Hoffman E. K., Horowitz M. P. et al. (2009) A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson’s disease. Neurobiol. Dis. 34, 417431.
  • Matute C. (2011) Glutamate and ATP signalling in white matter pathology. J. Anat. 219, 5364.
  • Matute C., Sánchez-Gómez M. V., Martínez-Millán L. and Miledi R. (1997) Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc. Natl Acad. Sci. USA 94, 88308835.
  • Matzner Y., Hershko C., Polliack A., Konijn A. M. and Izak G. (1979) Suppressive effect of ferritin on in vitro lymphocyte function. Br. J. Haematol. 42, 345353.
  • McFarland H. F. and Martin R. (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8, 913919.
  • McGahan M. C., Harned J., Mukunnemkeril M., Goralska M., Fleisher L. and Ferrell J. B. (2005) Iron alters glutamate secretion by regulating cytosolic aconitase activity. Am. J. Physiol. Cell Physiol. 288, C11171124.
  • Mehindate K., Sahlas D. J., Frankel D., Mawal Y., Liberman A., Corcos J., Dion S. and Schipper H. M. (2001) Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J. Neurochem. 77, 13861395.
  • Mitchell K. M., Dotson A. L., Cool K. M., Chakrabarty A., Benedict S. H. and LeVine S. M. (2007) Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis. Mult. Scler. 13, 11181126.
  • Miyachi S., Lu X., Imanishi M., Sawada K., Nambu A. and Takada M. (2006) Somatotopically arranged inputs from putamen and subthalamic nucleus to primary motor cortex. Neurosci. Res. 56, 300308.
  • Moos T. and Morgan E. H. (2000) Transferrin and transferrin receptor function in brain barrier systems. Cell. Mol. Neurobiol. 20, 7795.
  • Moos T. and Morgan E. H. (2004) The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann. NY Acad. Sci. 1012, 1426.
  • Moos T., Trinder D. and Morgan E. H. (2000) Cellular distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT1) in substantia nigra and basal ganglia of normal and beta2-microglobulin deficient mouse brain. Cell. Mol. Biol. (Noisy-le-grand) 46, 549561.
  • Moos T., Rosengren Nielsen T., Skjorringe T. and Morgan E. H. (2007) Iron trafficking inside the brain. J. Neurochem. 103, 17301740.
  • Neema M., Arora A., Healy B. C. et al. (2009) Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J. Neuroimaging 19, 38.
  • Norstrand I. F. and Craelius W. (1989) A trial of deferoxamine (Desferal) in the treatment of multiple sclerosis. A pilot study. Clinical Trials 26, 365369.
  • Omori N., Maruyama K., Jin G., Li F., Wang S. J., Hamakawa Y., Sato K., Nagano I., Shoji M. and Abe K. (2003) Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrin. Neurol. Res. 25, 275279.
  • Ong W. Y., Ren M. Q., Makjanic J., Lim T. M. and Watt F. (1999) A nuclear microscopic study of elemental changes in the rat hippocampus after kainate-induced neuronal injury. J. Neurochem. 72, 15741579.
  • Onyango I. G., Lu J., Rodova M., Lezi E., Crafter A. B. and Swerdlow R. H. (2010) Regulation of neuron mitochondrial biogenesis and relevance to brain health. Biochim. Biophys. Acta 1802, 228234.
  • Onyszchuk G., LeVine S. M., Brooks W. M. and Berman N. E. (2009) Post-acute pathological changes in the thalamus and internal capsule in aged mice following controlled cortical impact injury: a magnetic resonance imaging, iron histochemical, and glial immunohistochemical study. Neurosci. Lett. 452, 204208.
  • Oweida A. J., Dunn E. A., Karlik S. J., Dekaban G. A. and Foster P. J. (2007) Iron-oxide labeling of hematogenous macrophages in a model of experimental autoimmune encephalomyelitis and the contribution to signal loss in fast imaging employing steady state acquisition (FIESTA) images. J. Magn. Reson. Imaging 26, 144151.
  • Pampliega O., Domercq M., Soria F. N., Villoslada P., Rodríguez-Antigüedad A. and Matute C. (2011) Increased expression of cystine/glutamate antiporter in multiple sclerosis. J. Neuroinflammation 8, 63.
  • Paradkar P. N. and Roth J. A. (2006) Nitric oxide transcriptionally down-regulates specific isoforms of divalent metal transporter (DMT1) via NF-kappaB. J. Neurochem. 96, 17681777.
  • Pedchenko T. V. and LeVine S. M. (1998) Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice. J. Neuroimmunol. 84, 188197.
  • Pelizzoni I., Macco R., Morini M. F., Zacchetti D., Grohovaz F. and Codazzi F. (2011) Iron handling in hippocampal neurons: activity-dependent iron entry and mitochondria-mediated neurotoxicity. Aging Cell 10, 172183.
  • Penkowa M., Espejo C., Martinez-Caceres E. M., Poulsen C. B., Montalban X. and Hidalgo J. (2001) Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 119, 248260.
  • Peterson J. W., Bö L., Mörk S., Chang A. and Trapp B. D. (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50, 389400.
  • Petzold A., Eikelenboom M. J., Gveric D. et al. (2002) Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. Brain 125, 14621473.
  • Piñero D. J. and Connor J. R. (2000) Iron in the brain: an important contributor in normal and diseased states. Neuroscientist 6, 435453.
  • Pirko I., Johnson A. J., Lohrey A. K., Chen Y. and Ying J. (2009) Deep gray matter T2 hypointensity correlates with disability in a murine model of MS. J. Neurol. Sci. 282, 3438.
  • Pirko I., Johnson A. J., Chen Y., Lindquist D. M., Lohrey A. K., Ying J. and Dunn R. S. (2011) Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis. Neuroimage 54, 802806.
  • Prinster A., Quarantelli M., Orefice G. et al. (2006) Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. Neuroimage 29, 859867.
  • Proescholdt M. A., Jacobson S., Tresser N., Oldfield E. H. and Merrill M. J. (2002) Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J. Neuropathol. Exp. Neurol. 61, 914925.
  • Putnam T. (1937) Evidences of vascular occlusion in multiple sclerosis and “encephalomyelitis”. Arch. Neurol. Psychiatry 37, 12981321.
  • Qian Z. M., Wu X. M., Fan M., Yang L., Du F., Yung W. H. and Ke Y. (2011) Divalent metal transporter 1 is a hypoxia-inducible gene. J. Cell. Physiol. 226, 15961603.
  • Rajan K. S., Colburn R. W. and Davis J. M. (1976) Distribution of metal ions in the subcellular fractions of several rat brain areas. Life Sci. 18, 423431.
  • Ram M., Sherer Y. and Shoenfeld Y. (2006) Matrix metalloproteinase-9 and autoimmune diseases. J. Clin. Immunol. 26, 299307.
  • Ramagopalan S. V., Cukjati M., Cernilec M., DeLuca G. C., Dyment D. A., Degenhardt A., Sadovnick A. D., Serbec V. C., Ebers G. C. and Duquette P. (2008) Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis. J. Neuroimmunol. 203, 104107.
  • Rausch M., Hiestand P., Foster C. A., Baumann D. R., Cannet C. and Rudin M. (2004) Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. J. Magn. Reson. Imaging 20, 1624.
  • Recalcati S., Invernizzi P., Arosio P. and Cairo G. (2008) New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J. Autoimmun. 30, 8489.
  • Richardson D. R., Lane D. J., Becker E. M., Huang M. L., Whitnall M., Rahmanto Y. S., Sheftel A. D. and Ponka P. (2010) Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc. Natl Acad. Sci. USA 107, 1077510782.
  • Ristić S., Lovrecić L., Brajenović-Milić B., Starcević-Cizmarević N., Jazbec S. S., Sepcić J., Kapović M. and Peterlin B. (2005) Mutations in the hemochromatosis gene (HFE) and multiple sclerosis. Neurosci. Lett. 383, 301304.
  • Robb S. J. and Connor J. R. (1998) An in vitro model for analysis of oxidative death in primary mouse astrocytes. Brain Res. 788, 125132.
  • Robb S. J., Robb-Gaspers L. D., Scaduto Jr R. C., Thomas A. P. and Connor J. R. (1999) Influence of calcium and iron on cell death and mitochondrial function in oxidatively stressed astrocytes. J. Neurosci. Res. 55, 674686.
  • Roediger B. and Armati P. J. (2003) Oxidative stress induces axonal beading in cultured human brain tissue. Neurobiol. Dis. 13, 222229.
  • Rogers J. T., Bridges K. R., Durmowicz G. P., Glass J., Auron P. E. and Munro H. N. (1990) Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1. J. Biol. Chem. 265, 1457214578.
  • Roscoe W. A., Welsh M. E., Carter D. E. and Karlik S. J. (2009) VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. J. Neuroimmunol. 209, 615.
  • Ruiz de Almodovar C., Lambrechts D., Mazzone M. and Carmeliet P. (2009) Role and therapeutic potential of VEGF in the nervous system. Physiol. Rev. 89, 60748.
  • Russo C., Smoker W. R. and Kubal W. (1997) Cortical and subcortical T2 shortening in multiple sclerosis. AJNR Am. J. Neuroradiol. 18, 124126.
  • Ruuls S. R., Bauer J., Sontrop K., Huitinga I., t Hart B. A. and Dijkstra C. D. (1995) Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 56, 207217.
  • Salazar J., Mena N., Hunot S. et al. (2008) Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson’s disease. Proc. Natl Acad. Sci. USA 105, 1857818583.
  • Saleh M. C., Espinosa de los Monteros A., de Arriba Zerpa G. A. et al. (2003) Myelination and motor coordination are increased in transferrin transgenic mice. J. Neurosci. Res. 72, 587594.
  • Saleppico S., Mazzolla R., Boelaert J. R., Puliti M., Barluzzi R., Bistoni F. and Blasi E. (1996) Iron regulates microglial cell-mediated secretory and effector functions. Cell. Immunol. 170, 251259.
  • Sastry S. and Arendash G. W. (1995) Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex. Neuroscience 67, 649666.
  • Sayre L. M., Moreira P. I., Smith M. A. and Perry G. (2005) Metal ions and oxidative protein modification in neurological disease. Ann. Ist. Super. Sanita. 41, 143164.
  • Seabrook T. J., Littlewood-Evans A., Brinkmann V., Pöllinger B., Schnell C. and Hiestand P. C. (2010) Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions. J. Neuroinflammation 7, 95.
  • Sfagos C., Makis A. C., Chaidos A., Hatzimichael E. C., Dalamaga A., Kosma K. and Bourantas K. L. (2005) Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients. Mult. Scler. 11, 272275.
  • Sharp C. D., Hines I., Houghton J. et al. (2003) Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am. J. Physiol. Heart Circ. Physiol. 285, H2592H2598.
  • Sharp C. D., Houghton J., Elrod J. W., Warren A., Jackson 4th T. H., Jawahar A., Nanda A., Minagar A. and Alexander J. S. (2005) N-methyl-D-aspartate receptor activation in human cerebral endothelium promotes intracellular oxidant stress. Am. J. Physiol. Heart Circ. Physiol. 288, H1893H1899.
  • Shoham S., Wertman E. and Ebstein R. P. (1992) Iron accumulation in the rat basal ganglia after excitatory amino acid injections--dissociation from neuronal loss. Exp. Neurol. 118, 227241.
  • Silkis I. (2001) The cortico-basal ganglia-thalamocortical circuit with synaptic plasticity. II. Mechanism of synergistic modulation of thalamic activity via the direct and indirect pathways through the basal ganglia. Biosystems 59, 714.
  • Sindrilaru A., Peters T., Wieschalka S. et al. (2011) An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J. Clin. Invest. 121, 985997.
  • Singh A. V. and Zamboni P. (2009) Anomalous venous blood flow and iron deposition in multiple sclerosis. J. Cereb. Blood Flow Metab. 29, 18671878.
  • Sinor A. D., Irvin S. M., Cobbs C. S., Chen J., Graham S. H. and Greenberg D. A. (1998) Hypoxic induction of vascular endothelial growth factor (VEGF) protein in astroglial cultures. Brain Res. 812, 289291.
  • Smirnov I. M., Bailey K., Flowers C. H., Garrigues N. W. and Wesselius L. J. (1999) Effects of TNF-alpha and IL-1beta on iron metabolism by A549 cells and influence on cytotoxicity. Am. J. Physiol. 277, L257L263.
  • Srinivasan R., Sailasuta N., Hurd R., Nelson S. and Pelletier D. (2005) Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 128, 10161025.
  • Srinivasan R., Ratiney H., Hammond-Rosenbluth K. E., Pelletier D. and Nelson S. J. (2010) MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis. Magn. Reson. Imaging 28, 163170.
  • Stoll G., Wesemeier C., Gold R., Solymosi L., Toyka K. V. and Bendszus M. (2004) In vivo monitoring of macrophage infiltration in experimental autoimmune neuritis by magnetic resonance imaging. J. Neuroimmunol. 149, 142146.
  • Sun D., Tani M., Newman T. A. et al. (2000) Role of chemokines, neuronal projections, and the blood-brain barrier in the enhancement of cerebral EAE following focal brain damage. J. Neuropathol. Exp. Neurol. J. Neuropathol. Exp. Neurol. 59, 10311043.
  • Sundstrom P., Wahlin A., Ambarki K., Birgander R., Eklund A. and Malm J. (2010) Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study. Ann. Neurol. 68, 255259.
  • Sweeney M. E., Slusser J. G., Lynch S. G., Benedict S. H., Garcia S. L., Rues L. and LeVine S. M. (2011) Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects. Int. Immunopharmacol. 11, 17961801.
  • Tacchini L., Gammella E., De Ponti C., Recalcati S. and Cairo G. (2008) Role of HIF-1 and NF-kappaB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals. J. Biol. Chem. 283, 2067420686.
  • Takeuchi H., Mizuno T., Zhang G., Wang J., Kawanokuchi J., Kuno R. and Suzumura A. (2005) Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J. Biol. Chem. 280, 1044410454.
  • Tanaka R., Iwasaki Y. and Koprowski H. (1975) Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. Am. J. Pathol. 81, 467478.
  • Taylor M. C. and Kelly J. M. (2010) Iron metabolism in trypanosomatids, and its crucial role in infection. Parasitology 137, 899917.
  • Tjoa C. W., Benedict R. H., Weinstock-Guttman B., Fabiano A. J. and Bakshi R. (2005) MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J. Neurol. Sci. 234, 1724.
  • Todorich B., Zhang X., Slagle-Webb B., Seaman W. E. and Connor J. R. (2008) Tim-2 is the receptor for H-ferritin on oligodendrocytes. J. Neurochem. 107, 14951505.
  • Todorich B., Pasquini J. M., Garcia C. I., Paez P. M. and Connor J. R. (2009) Oligodendrocytes and myelination: the role of iron. Glia 57, 467478.
  • Todorich B., Zhang X. and Connor J. R. (2011) H-ferritin is the major source of iron for oligodendrocytes. Glia 59, 927935.
  • van Toorn R., Schoeman J. F., Solomons R., Rensburg M. A. and van Rensburg S. J. (2010) Iron status in children with recurrent episodes of tumefactive cerebral demyelination. J. Child Neurol. 25, 14011407.
  • Tovar-Y-Romo L. B. and Tapia R. (2010) VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo by activation of PI3-K pathway and inhibition of p38MAPK. J. Neurochem. 115, 10901101.
  • Trapp B. D. and Stys P. K. (2009) Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 8, 280291.
  • Trapp B. D., Peterson J., Ransohoff R. M., Rudick R., Mork S. and Bo L. (1998) Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278285.
  • Trapp B. D., Ransohoff R. and Rudick R. (1999) Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol. 12, 295302.
  • Trebst C., Staugaitis S. M., Tucky B., Wei T., Suzuki K., Aldape K. D., Pardo C. A., Troncoso J., Lassmann H. and Ransohoff R. M. (2003) Chemokine receptors on infiltrating leucocytes in inflammatory pathologies of the central nervous system (CNS). Neuropathol. Appl. Neurobiol. 29, 584595.
  • Trigwell S. M., Radford P. M., Page S. R., Loweth A. C., James R. F., Morgan N. G. and Todd I. (2001) Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus. Clin. Exp. Immunol. 126, 242249.
  • Tsuji Y., Miller L. L., Miller S. C., Torti S. V. and Torti F. M. (1991) Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain. J. Biol. Chem. 266, 72577261.
  • Vercellino M., Plano F., Votta B., Mutani R., Giordana M. T. and Cavalla P. (2005) Grey matter pathology in multiple sclerosis. J. Neuropathol. Exp. Neurol. 64, 11011107.
  • Vercellino M., Merola A., Piacentino C., Votta B., Capello E., Mancardi G. L., Mutani R., Giordana M. T. and Cavalla P. (2007) Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J. Neuropathol. Exp. Neurol. 66, 732739.
  • Vercellino M., Masera S., Lorenzatti M. et al. (2009) Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J. Neuropathol. Exp. Neurol. 68, 489502.
  • Wakefield A. J., More L. J., Difford J. and McLaughlin J. E. (1994) Immunohistochemical study of vascular injury in acute multiple sclerosis. J. Clin. Pathol. 47, 129133.
  • Wang J. and Pantopoulos K. (2011) Regulation of cellular iron metabolism. Biochem. J. 434, 365381.
  • Wang X. S., Ong W. Y. and Connor J. R. (2002) Increase in ferric and ferrous iron in the rat hippocampus with time after kainate-induced excitotoxic injury. Exp. Brain Res. 143, 137148.
  • Warnke C., Meyer Zu Hörste G., Hartung H. P., Stüve O. and Kieseier B. C. (2009) Review of teriflunomide and its potential in the treatment of multiple sclerosis. Neuropsychiatr. Dis. Treat. 5, 333340.
  • Werner P., Pitt D. and Raine C. S. (2001) Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann. Neurol. 50, 169180.
  • Williams R., Rohr A. M., Wang W.-T., Choi I.-Y., Lee P., Berman N. E. J., Lynch S. G. and LeVine S. M. (2011) Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis. BMC Neuroscience 12, 59.
  • Witte M. E., Bo L., Rodenburg R. J. et al. (2009) Enhanced number and activity of mitochondria in multiple sclerosis lesions. J. Pathol. 219, 193204.
  • Wong R. (2006) NMDA receptors expressed in oligodendrocytes. Bioessays 28, 460464.
  • Worthington V., Killestein J., Eikelenboom M. J., Teunissen C. E., Barkhof F., Polman C. H., Uitdehaag B. M. and Petzold A. (2010) Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency. Neurol. 75, 16171622.
  • Xu X., Wang Q. and Zhang M. (2008) Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study. Neuroimage 40, 3542.
  • Yin W., Signore A. P., Iwai M., Cao G., Gao Y. and Chen J. (2008) Rapidly increased neuronal mitochondrial biogenesis after hypoxic-ischemic brain injury. Stroke 39, 30573063.
  • Yu J., Guo Y., Sun M., Li B., Zhang Y. and Li C. (2009) Iron is a potential key mediator of glutamate excitotoxicity in spinal cord motor neurons. Brain Res. 1257, 102107.
  • Zamboni P. (2006) The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J. R. Soc. Med. 99, 589593.
  • Zamboni P., Scapoli G., Lanzara V., Izzo M., Fortini P., Legnaro R., Palazzo A., Tognazzo S. and Gemmati D. (2005) Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers. Dermatol. Surg. 31, 644649.
  • Zamboni P., Menegatti E., Bartolomei I., Galeotti R., Malagoni A. M., Tacconi G. and Salvi F. (2007) Intracranial venous haemodynamics in multiple sclerosis. Curr. Neurovasc. Res. 4, 252258.
  • Zamboni P., Lanzara S., Mascoli F., Caggiati A. and Liboni A. (2008) Inflammation in venous disease. Int. Angiol. 27, 361369.
  • Zhang Z. G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N. and Chopp M. (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829838.
  • Zhang X., Haaf M., Todorich B., Grosstephan E., Schieremberg H., Surguladze N. and Connor J. R. (2005) Cytokine toxicity to oligodendrocyte precursors is mediated by iron. Glia 52, 199208.
  • Zhang X., Surguladze N., Slagle-Webb B., Cozzi A. and Connor J. R. (2006) Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 54, 795804.
  • Zhang Y., Zabad R. K., Wei X., Metz L. M., Hill M. D. and Mitchell J. R. (2007) Deep grey matter “black T2” on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult. Scler. 13, 880883.
  • Zhang S., Wang J., Song N., Xie J. and Jiang H. (2009) Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells. Neurobiol. Aging 30, 14661476.